134 related articles for article (PubMed ID: 38404909)
1. Impact of steroid use and glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy.
Kincaid K; Boitano TKL; Scalise M; Patton S; Leath CA; Straughn JM; Smith HJ
Gynecol Oncol Rep; 2024 Apr; 52():101344. PubMed ID: 38404909
[TBL] [Abstract][Full Text] [Related]
2. Perioperative glycemic measures among non-fasting gynecologic oncology patients receiving carbohydrate loading in an enhanced recovery after surgery (ERAS) protocol.
Alimena S; Falzone M; Feltmate CM; Prescott K; Contrino Slattery L; Elias K
Int J Gynecol Cancer; 2020 Apr; 30(4):533-540. PubMed ID: 32107317
[TBL] [Abstract][Full Text] [Related]
3. The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: a prospective longitudinal cohort study.
Doll KM; Barber EL; Bensen JT; Revilla MC; Snavely AC; Bennett AV; Reeve BB; Gehrig PA
Am J Obstet Gynecol; 2016 Oct; 215(4):457.e1-457.e13. PubMed ID: 27131589
[TBL] [Abstract][Full Text] [Related]
4. An enhanced recovery protocol decreases complication rates in high-risk gynecologic oncology patients undergoing non-emergent laparotomy.
Boitano TKL; Smith HJ; Cohen AC; Todd A; Leath Iii CA; Straughn JM
Int J Gynecol Cancer; 2021 May; 31(5):721-726. PubMed ID: 33495207
[TBL] [Abstract][Full Text] [Related]
5. Impact of enhanced recovery after surgery (ERAS) protocol on gastrointestinal function in gynecologic oncology patients undergoing laparotomy.
Boitano TKL; Smith HJ; Rushton T; Johnston MC; Lawson P; Leath CA; Xhaja A; Guthrie MP; Straughn JM
Gynecol Oncol; 2018 Nov; 151(2):282-286. PubMed ID: 30244961
[TBL] [Abstract][Full Text] [Related]
6. Perioperative Laboratory Abnormalities in Gynecologic Oncology Surgical Patients.
Burnett TL; Junn J; Kolenic GE; Christen C; Johnston CM; Reynolds RK; McLean K
J Gynecol Surg; 2016 Apr; 32(2):111-118. PubMed ID: 27041975
[No Abstract] [Full Text] [Related]
7. Perioperative Hyperglycemia and Glucose Variability in Gynecologic Laparotomies.
Polderman JA; Hollmann MW; DeVries JH; Preckel B; Hermanides J
J Diabetes Sci Technol; 2015 Jul; 10(1):145-50. PubMed ID: 26199042
[TBL] [Abstract][Full Text] [Related]
8. Postoperative complications of epidural analgesia at hysterectomy for gynecologic malignancies: an analysis of the National Surgical Quality Improvement Program.
Ackroyd SA; Hernandez E; Roberts ME; Chu C; Rubin S; Mantia-Smaldone G; Houck K
Int J Gynecol Cancer; 2020 Aug; 30(8):1203-1209. PubMed ID: 32457094
[TBL] [Abstract][Full Text] [Related]
9. Perioperative Glycemic Surveillance and Control-Current Practices, Efficacy and Impact on Postoperative Outcomes following Infrainguinal Vascular Intervention.
Kinio AE; Gold M; Doonan RJ; Steinmetz O; Mackenzie K; Obrand D; Girsowicz E; Bayne J; Gill HL
Ann Vasc Surg; 2023 Sep; 95():108-115. PubMed ID: 37003358
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a referral to discharge glycemic control initiative for reduction of surgical site infections in gynecologic oncology patients.
Hopkins L; Brown-Broderick J; Hearn J; Malcolm J; Chan J; Hicks-Boucher W; De Sousa F; Walker MC; Gagné S
Gynecol Oncol; 2017 Aug; 146(2):228-233. PubMed ID: 28532856
[TBL] [Abstract][Full Text] [Related]
11. GLYCEMIC OUTCOMES 3 YEARS AFTER IMPLEMENTATION OF A PERI-OPERATIVE GLYCEMIC CONTROL ALGORITHM IN AN ACADEMIC INSTITUTION.
Arnold LM; Mahesri M; McDonnell ME; Alexanian SM
Endocr Pract; 2017 Feb; 23(2):123-131. PubMed ID: 27819771
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?
Swift BE; Maeda A; Bouchard-Fortier G
Gynecol Oncol; 2022 Feb; 164(2):311-317. PubMed ID: 34920887
[TBL] [Abstract][Full Text] [Related]
13. Poor glycemic control is a strong predictor of postoperative morbidity and mortality in patients undergoing vascular surgery.
Long CA; Fang ZB; Hu FY; Arya S; Brewster LP; Duggan E; Duwayri Y
J Vasc Surg; 2019 Apr; 69(4):1219-1226. PubMed ID: 30459015
[TBL] [Abstract][Full Text] [Related]
14. Thirty-day outcomes after gynecologic oncology surgery: A single-center experience of enhanced recovery after surgery pathways.
Bernard L; McGinnis JM; Su J; Alyafi M; Palmer D; Potts L; Nancekivell KL; Thomas H; Kokus H; Eiriksson LR; Elit LM; Jimenez WGF; Reade CJ; Helpman L
Acta Obstet Gynecol Scand; 2021 Feb; 100(2):353-361. PubMed ID: 33000463
[TBL] [Abstract][Full Text] [Related]
15. Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients.
Boitano TKL; Gardner A; Chu DI; Leath CA; Straughn JM; Smith HJ
Gynecol Oncol; 2023 Nov; 178():23-26. PubMed ID: 37742507
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glucose control by added liraglutide to only insulin infusion in diabetic patient undergoing cardiac surgery: A preliminary randomized-controlled trial.
Sindhvananda W; Poopuangpairoj W; Jaiprasat T; Ongcharit P
Ann Card Anaesth; 2023; 26(1):63-71. PubMed ID: 36722590
[TBL] [Abstract][Full Text] [Related]
17. Postoperative complications and pelvic organ prolapse recurrence following combined pelvic organ prolapse and rectal prolapse surgery compared with pelvic organ prolapse only surgery.
Wallace SL; Kim Y; Lai E; Mehta S; Gaigbe-Togbe B; Zhang CA; Von Bargen EC; Sokol ER
Am J Obstet Gynecol; 2022 Aug; 227(2):317.e1-317.e12. PubMed ID: 35654113
[TBL] [Abstract][Full Text] [Related]
18. Use of prophylactic closed incision negative pressure therapy is associated with reduced surgical site infections in gynecologic oncology patients undergoing laparotomy.
Chambers LM; Morton M; Lampert E; Yao M; Debernardo R; Rose PG; Vargas R
Am J Obstet Gynecol; 2020 Nov; 223(5):731.e1-731.e9. PubMed ID: 32417358
[TBL] [Abstract][Full Text] [Related]
19. Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study.
Oba T; Nagao M; Kobayashi S; Yamaguchi Y; Nagamine T; Tanimura-Inagaki K; Fukuda I; Sugihara H
Ther Adv Endocrinol Metab; 2022; 13():20420188221099349. PubMed ID: 35646304
[TBL] [Abstract][Full Text] [Related]
20. The five-factor modified frailty index predicts adverse postoperative and chemotherapy outcomes in gynecologic oncology.
Mah SJ; Anpalagan T; Marcucci M; Eiriksson L; Reade CJ; Jimenez W; Carlson V; Nguyen JMV
Gynecol Oncol; 2022 Jul; 166(1):154-161. PubMed ID: 35606168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
